C9orf72 and amyotrophic lateral sclerosis: While initially extra-motor pathology was primarily associated with GGGGCC hexanucleotide repeat expansions in C9orf72 [18, 19], more recent papers have clarified that significant frontotemporal atrophy and subcortical pathology in ALS are not unique to C9orf72 carriers [20].